Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 2.080
-0.060 (-2.80%)
Oct 9, 2026, 3:59 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 205.33 million as of October 9, 2026. It is the 22,991st most valuable company in the world and the 600th biggest in Canada. Its market cap has increased by 22.25% in one year.
Market Cap
205.33M
Enterprise Value
220.52M
Revenue
117.33M
Global Rank
Country Rank
#600 Canada
PE Ratio
18.92
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 205.33M, a decrease of -2.97%. That is a compound annual growth rate of -0.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 205.33M | 24.24% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 346.92M |
| Cresco Labs | 341.28M |
| Auxly Cannabis Group | 336.55M |
| Cardiol Therapeutics | 216.12M |
| TerrAscend | 213.33M |
| Organigram Global | 193.18M |
| BioSyent | 191.29M |
| Medexus Pharmaceuticals | 156.82M |